A statement from Lezlee Westine, President & CEO, Personal Care Products Council
The Personal Care Products Council (PCPC) is dedicated to collaborating with the U.S. Food and Drug Administration (FDA) to safeguard consumer health and comprehend the potential impact of the FDA's proposed reorganization on the regulation of cosmetics and personal care products. The PCPC remains committed to supporting the Agency and other stakeholders to ensure that any reorganization will allow the beauty and personal care industry to provide innovative, safe, and effective products while maintaining consumer trust, as we have done in the past.
Our immediate focus is working closely with the FDA to effectively execute the Modernization of Cosmetics Regulation Act (MoCRA) of 2022. This groundbreaking legislation provides the FDA with additional tools to ensure cosmetics safety and protect public health, thereby strengthening consumer confidence in the products they rely on daily. MoCRA also aligns the FDA's oversight of the beauty and personal care sector with other categories the Agency regulates, contributing to global regulatory coherence. We welcome the leadership of Dr. Namandjé Bumpus, the FDA's Chief Scientist, who will oversee MoCRA's implementation since cosmetics and personal care products will now be handled by the Office of the Chief Scientist within the Office of the Commissioner. We believe that the Commissioner's decision is the right one.
As the FDA moves forward with the proposed reorganization, our industry is committed to working with the Agency and providing our expertise to promote appropriate regulation of cosmetics and personal care products. We acknowledge the significance of transparency in regulatory decision-making and will continue to advocate for a transparent, science-based, and risk-based approach to regulation.
For more information on cosmetics and personal care products and their ingredients, please visit www.CosmeticsInfo.org.